Cyclacel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 75%.

Top 25 shareholders own 33.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.91%	Armistice Capital LLC	145,000	US$234.9k	0%	0.01%
6.99%	The Lind Partners, LLC	102,250	US$165.6k	0%	1.04%
5.61%	Altium Capital Management LP	82,032	US$132.9k	0%	0.08%
2.05%	Spiro Rombotis	30,000	US$48.6k	1.18%	no data
1.42%	Renaissance Technologies LLC	20,838	US$33.8k	44.3%	no data
1.14%	Brian Schwartz	16,707	US$27.1k	167%	no data
1.11%	Paul McBarron	16,241	US$26.3k	1.15%	no data
1.05%	Point72 Asset Management, L.P.	15,333	US$24.8k	0%	no data
0.98%	Acadian Asset Management LLC	14,285	US$23.1k	-41%	no data
0.4%	The Vanguard Group, Inc.	5,796	US$9.4k	0%	no data
0.39%	Geode Capital Management, LLC	5,761	US$9.3k	0%	no data
0.33%	UBS Asset Management AG	4,835	US$7.8k	0%	no data
0.29%	Karin Walker	4,207	US$6.8k	0.62%	no data
0.29%	Tower Research Capital LLC	4,188	US$6.8k	419%	no data
0.28%	Samuel Barker	4,155	US$6.7k	0%	no data
0.28%	Christopher Henney	4,089	US$6.6k	0%	no data
0.28%	Robert Jay Spiegel	4,073	US$6.6k	0%	no data
0.26%	Kenneth Ferguson	3,875	US$6.3k	63.3%	no data
0.13%	Schonfeld Strategic Advisors LLC	1,900	US$3.1k	0%	no data
0.057%	McIlrath & Eck, LLC	832	US$1.3k	0%	no data
0.0086%	Osaic Wealth, Inc. , Asset Management Arm	126	US$204.1	0%	no data
0.0055%	Morgan Stanley, Investment Banking and Brokerage Investments	80	US$129.7	0%	no data
0.0023%	Wells Fargo & Company, Securities and Brokerage Investments	33	US$53.6	0%	no data
0.0014%	SignatureFD, LLC	20	US$32.5	0%	no data
0.00089%	Harbour Investments, Inc.	13	US$21.1	0%	no data